Page last updated: 2024-10-20

uric acid and Multiple Endocrine Neoplasia Type 1

uric acid has been researched along with Multiple Endocrine Neoplasia Type 1 in 1 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Multiple Endocrine Neoplasia Type 1: A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MATTEINI, M1
BARTOLI, V1
ANDREOTTI, L1
BENCINI, A1

Other Studies

1 other study available for uric acid and Multiple Endocrine Neoplasia Type 1

ArticleYear
[The metabolic effects of active somatotropin preparations in man. I. Carbohydrate metabolism, blood levels of phosphorus, alkaline phosphatases, cholesterol, uric acid and creatinine and urinary levels of phosphate].
    Bollettino della Societa italiana di biologia sperimentale, 1958, Oct-31, Volume: 34, Issue:20

    Topics: Alkaline Phosphatase; Carbohydrate Metabolism; Carbohydrates; Cholesterol; Creatinine; Growth Hormon

1958